Century Sage Scientific Holdings Limited

HKEX:1450.HK

1.13 (HKD) • At close November 5, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) HKD.

20232022202120202019201820172016201520142013
Omzet 1,074.335425.606202.788153.306191.03298.704462.78662.888623.432748.535628.758
Kosten van de omzet 507.425235.81142.45797.455142.443237.579335.713467.616440.488517.583435.198
Brutowinst 566.91189.79660.33155.85148.58761.125127.067195.272182.944230.952193.56
Brutowinstmarge 0.5280.4460.2980.3640.2540.2050.2750.2950.2930.3090.308
Onderzoek- en ontwikkelingskosten 00.0270.1759.8184.4543.7513.051.7510.3390.025.275
Algemene en administratieve kosten 173.646107.84776.17279.559108.99696.73790.0393.10385.84778.05162.928
Verkoop- en marketingkosten 261.67870.8610.92910.92219.92525.46529.02635.47734.68532.56733.356
Verkoop-, algemene en administratieve kosten 435.324178.79993.225112.248130.977122.202119.056128.58120.532110.61896.284
Overige kosten -0.1740.0250.3290.1982.3570.71300000
Bedrijfskosten 431.084181.668118.058144.029123.55376.68275.806125.496120.344115.595.923
Bedrijfsresultaat 145.78113.785-27.454-52.087-78.302-55.63516.05170.28666.526120.93697.508
Bedrijfsresultaat ratio 0.1360.032-0.135-0.34-0.41-0.1860.0350.1060.1070.1620.155
Totaal overige inkomsten en kosten netto 12.863-19.841-44.78-47.571-13.23724.989-182.336-8.858-9.349-8.796-3.362
Inkomen voor belasting 139.519-6.056-72.234-99.658-91.539-30.646-166.28561.42857.177112.1494.146
Inkomen voor belasting ratio 0.13-0.014-0.356-0.65-0.479-0.103-0.3590.0930.0920.150.15
Belastingkosten 25.54810.3353.511.7012.8958.1561.398.8817.0915.08716.391
Nettowinst 119.462-9.207-61.615-97.531-84.325-38.606-170.2451.39650.08797.05377.755
Nettowinstmarge 0.111-0.022-0.304-0.636-0.441-0.129-0.3680.0780.080.130.124
WPA (Winst Per Aandeel) 0.091-0.008-0.058-0.094-0.082-0.038-0.170.0510.050.110.1
Verwaterde WPA 0.087-0.008-0.058-0.094-0.082-0.038-0.170.0510.050.110.1
EBITDA 174.17318.009-22.515-44.957-70.639-45.14425.43282.30177.539130.524105.843
EBITDA ratio 0.1620.042-0.111-0.293-0.37-0.1510.0550.1240.1240.1740.168